During the past decade, Centrum pro choroby srdce a cev conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum pro choroby srdce a cev" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cordis Corporation" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Centrum pro choroby srdce a cev" are "Atrial Fibrillation" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Centrum pro choroby srdce a cev" in a lesser frequency.

Most popular intervention types in "Centrum pro choroby srdce a cev" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Clopidogrel & Aspirin, Prasugrel & Aspirin" (1 trials), "Edoxaban" (1 trials) and "Placebo & Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum pro choroby srdce a cev" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centrum pro choroby srdce a cev". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centrum pro choroby srdce a cev, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centrum pro choroby srdce a cev, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".